Ozempic (semaglutide) is a prescription once-weekly injectable medication approved to improve blood sugar in adults with type 2 diabetes and lower the risk of major cardiovascular events like heart attack and stroke. While often used off-label for weight loss, its FDA-approved sibling medication for chronic weight management is Wegovy.
- Mimics the natural GLP-1 hormone to trigger insulin release when blood sugar is high.
- Slows digestion down to keep food in the stomach longer, increasing the feeling of fullness.
- Reduces the amount of sugar released by the liver.
- Common: Nausea, vomiting, diarrhea, stomach pain, and constipation.
- Serious: Pancreatitis, gallbladder issues, low blood sugar, kidney damage from dehydration, and changes in vision.
- Boxed Warning: Causes thyroid C-cell tumors in animal studies; it should not be used by anyone with a personal or family history of medullary thyroid carcinoma.
- Administered as a subcutaneous injection once a week via a pre-filled pen.
- Average retail prices can exceed $1,200 per month before insurance coverage or savings coupons
Potential Side Effects
- Nausea and vomiting
- Diarrhea and constipation
- Stomach ache or gas
- Heartburn and burping
- Feeling very tired
- Less hunger
Important Considerations
- Triggers the pancreas to release insulin only when blood sugar goes high.
- Lowers sugar production by the liver.
- Lowers long-term A1C levels safely.
- Lowers the risk of heart attacks and strokes in people with heart disease.
- Slows down kidney damage and prevents worsening kidney failure.
- Treats obesity-related metabolic strain as a medical condition rather than a personal flaw




Reviews
There are no reviews yet.